publication venue for
- Exercise and nutrition in hematologic malignancies: translational evidence and emerging interventions.. 3:-. 2026
- Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT.. 3:-. 2026
- Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia.. 2:-. 2025